CA2506685A1 - Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity - Google Patents

Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity Download PDF

Info

Publication number
CA2506685A1
CA2506685A1 CA002506685A CA2506685A CA2506685A1 CA 2506685 A1 CA2506685 A1 CA 2506685A1 CA 002506685 A CA002506685 A CA 002506685A CA 2506685 A CA2506685 A CA 2506685A CA 2506685 A1 CA2506685 A1 CA 2506685A1
Authority
CA
Canada
Prior art keywords
gamma
guanidine
dimethylallyl
mmol
aminobutyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002506685A
Other languages
English (en)
French (fr)
Inventor
Fabio Giannessi
Emanuela Tassoni
Maria Ornella Tinti
Pompeo Pessotto
Maurizio Botta
Federico Corelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2506685A1 publication Critical patent/CA2506685A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
CA002506685A 2002-12-17 2003-12-01 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity Abandoned CA2506685A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000625A ITRM20020625A1 (it) 2002-12-17 2002-12-17 Derivati di guanidine variamente sostituite, loro uso come medicamenti ad attivita' antidiabetica e/o antiobesita'.
ITRM2002A000625 2002-12-17
PCT/IT2003/000792 WO2004054967A1 (en) 2002-12-17 2003-12-01 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity

Publications (1)

Publication Number Publication Date
CA2506685A1 true CA2506685A1 (en) 2004-07-01

Family

ID=32587901

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002506685A Abandoned CA2506685A1 (en) 2002-12-17 2003-12-01 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity

Country Status (12)

Country Link
US (1) US7368605B2 (https=)
EP (1) EP1575912A1 (https=)
JP (1) JP2006509816A (https=)
KR (1) KR20050089058A (https=)
CN (1) CN1729172A (https=)
AU (1) AU2003288534B2 (https=)
BR (1) BR0317397A (https=)
CA (1) CA2506685A1 (https=)
IT (1) ITRM20020625A1 (https=)
MX (1) MXPA05006326A (https=)
PL (1) PL378416A1 (https=)
WO (1) WO2004054967A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2873368B1 (fr) * 2004-07-26 2008-01-04 Merck Sante Soc Par Actions Si Derives de guanidine et leurs utilisations en therapeutique
CN101062906B (zh) * 2006-04-26 2012-02-08 中国人民解放军军事医学科学院毒物药物研究所 胍丁胺硫酸盐水合物及其用于戒毒,抗炎,降血糖以及胍丁胺代谢异常所致疾病的用途
CN101121677B (zh) * 2006-08-09 2011-05-11 中国人民解放军军事医学科学院毒物药物研究所 胍丁胺硫酸盐二水合物及其医药用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU190639B (en) * 1983-12-12 1986-09-29 Gyogyszerkutato Intezet Kv,Hu Process for production of new aminoguanidin derivatives
IT1219846B (it) * 1988-02-24 1990-05-24 Consiglio Nazionale Ricerche Nuovi derivati guandinici ad attivita' ipotensia,composizione che li contengono e relativo procedimento di estrazione e purificazione da materiale botanico
JPH06510760A (ja) * 1991-08-27 1994-12-01 ジ・アップジョン・カンパニー 代謝障害および代謝の治療法
GB9511757D0 (en) * 1995-05-19 1995-08-02 Univ Strathclyde Agents for reducing weight
KR19990076594A (ko) * 1995-12-22 1999-10-15 피터 존 기딩스 Niddm 치료용 아미노구아니딘

Also Published As

Publication number Publication date
CN1729172A (zh) 2006-02-01
WO2004054967A1 (en) 2004-07-01
AU2003288534B2 (en) 2009-07-02
PL378416A1 (pl) 2006-04-03
US7368605B2 (en) 2008-05-06
JP2006509816A (ja) 2006-03-23
KR20050089058A (ko) 2005-09-07
ITRM20020625A1 (it) 2004-06-18
EP1575912A1 (en) 2005-09-21
US20060069100A1 (en) 2006-03-30
BR0317397A (pt) 2005-11-16
AU2003288534A1 (en) 2004-07-09
MXPA05006326A (es) 2005-08-26

Similar Documents

Publication Publication Date Title
KR101274981B1 (ko) 바이구아나이드 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 약학 조성물
KR100339299B1 (ko) 일산화질소합성효소저해작용을갖는아닐린유도체
EP2203418B1 (en) N,n-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same
BG107581A (bg) Полиарилкарбоксамиди и използването им като средства, понижаващи липидите
SK4382002A3 (en) 2'-substituted 1,1'-biphenyl-2-carbonamides, method for the production thereof, use thereof as a medicament and pharmaceutical preparations containing said compounds
EP4563573A1 (en) Compound, and preparation method therefor and use thereof in preparation of seh inhibitor and ppars agonist
KR20130018622A (ko) Ｎ1-고리아민-ｎ5-치환된 바이구아나이드 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 약학 조성물
EP0324791B1 (en) Aryl-n-aminoalkyl-4-(sulfonamido)benzamides, antiarrhytmic agents and compositions thereof
US6127423A (en) Phenylamidine derivatives, a process for preparing the same and their use as medicaments
CA2506685A1 (en) Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity
JP3790557B2 (ja) ジアシル−置換されたグアニジン、それらの製法、医薬または診断剤としてのそれらの使用およびそれらを含有する医薬
US7939569B1 (en) Aniline analogs as glycogen synthase activators
US20010039279A1 (en) Diamide compounds and compositions containing the same
TW200932224A (en) Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders
US20160264527A1 (en) Insulin secretion promoting agents
US20240383869A1 (en) Arylacetyl inhibitors of tg2 and uses thereof
KR20130018623A (ko) Ｎ1-고리아민-ｎ2-치환된 바이구아나이드 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 약학 조성물
HU187706B (en) Process for preparing n-/aryl-oxy.alkyl/-n'-/amino-alkyl/-carbamide derivatives
NZ511167A (en) Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments
JP2005194191A (ja) 抗肥満薬、脂肪肝治療薬
CN121824357A (zh) 一种脲类衍生物及其制备方法和应用
Mutalabisin et al. Cyclic amines-modified metformin derivatives with enhanced glucose uptake activity
US9024069B2 (en) NONOate derivatives and uses thereof
Rakesh et al. Synthesis, characterization, molecular docking and antidiabetic evaluation of di (1H-imidazol-1-yl) methanone derivatives
KR20150051016A (ko) 구아니딘 화합물 및 이의 용도

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued